Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Clinical Pharmacology of 5-Fluorouracil
1989775 citationsRobert B. Diasio, Barry HarrisClinical Pharmacokineticsprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Barry Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Harris more than expected).
This network shows the impact of papers produced by Barry Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Harris. The network helps show where Barry Harris may publish in the future.
Co-authorship network of co-authors of Barry Harris
This figure shows the co-authorship network connecting the top 25 collaborators of Barry Harris.
A scholar is included among the top collaborators of Barry Harris based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Barry Harris. Barry Harris is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Harris, Barry, et al.. (1990). The role of dihydropyrimidine dehydrogenase (DPD) and thymidine phosphorylase (dthdPase) in the circadian variation of plasma drug levels of 5-fluorouracil (FUra) and 5-fluorodeoxyuridine (FdUrd) following infusion of FUra or FdUrd. 7. 227–230.7 indexed citations
Harris, Barry, Song Rong, Seng-Jaw Soong, & Robert B. Diasio. (1990). Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion.. PubMed. 50(1). 197–201.398 indexed citations
6.
Diasio, Robert B. & Barry Harris. (1989). Clinical Pharmacology of 5-Fluorouracil. Clinical Pharmacokinetics. 16(4). 215–237.775 indexed citations breakdown →
7.
Harris, Barry, et al.. (1989). Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liver.. PubMed. 49(23). 6610–4.42 indexed citations
Harris, Barry, Theresa P. Pretlow, Edwin L. Bradley, Garnett B. Whitehurst, & Thomas G. Pretlow. (1983). Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma.. PubMed. 43(6). 3008–12.32 indexed citations
Walbot, Virginia, Barry Harris, & Leon Dure. (1974). Regulation of enzyme synthesis in the embryogenesis and germination of cotton. Progress report, June 1973--June 1974. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information).1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.